Evidence map›Paper›PMID 33262200›Full record

ReviewESMO open2020

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.

Lisa Salvatore, Marco Imperatori, Ermenegildo Arnoldi, Carlo Carnaghi, Stefano Cordio, Maurizio Cosimelli, Chiara Cremolini, Evaristo Maiello, Erika Martinelli, Nicola Normanno and 8 more

Open access · goldAbstract readReview
In one paragraph

Review in ESMO open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 15 institutions in 1 country.

Lisa SalvatoreMedical Oncology, Comprehensive Cancer Center - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy. Electronic address: lisa.salvatore@policlinicogemelli.it.
Marco ImperatoriMedical Oncology, A.O.R. San Carlo, Potenza, Potenza, Italy.
Ermenegildo ArnoldiDepartment of Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
Carlo CarnaghiMedical Oncology, Humanitas Istituto Clinico Catanese, Catania, Sicilia, Italy.
Stefano CordioMedical Oncology, ASL 7 Ragusa, Ragusa, Sicilia, Italy.
Maurizio CosimelliDepartment of Colo-Rectal Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italy.
Chiara CremoliniDepartment of Oncology, Medical Oncology, Hospital of Pisa, Pisa, Italy.
Evaristo MaielloMedical Oncology, IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Puglia, Italy.
Erika MartinelliMedical Oncology, Department of Clinical and Experimental Medicine "F. Magrassi", Second University of Naples, Naples, Italy.
Nicola NormannoBiologia Cellulare e Bioterapie, INT-Fondazione Pascale, Napoli, Italy.
Stefania ScialleroDepartment of Oncology, Azienda Ospedaliera S.Martino IRCCS, IST, Genova, Italy.
Renato CannizzaroGastroenterologia Oncologica, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy.
Daniela MusioRadiotherapy, Umberto I Policlinico di Roma, Roma, Lazio, Italy.
Michela CinquiniIRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Ivan MoschettiIRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Veronica Andrea FittipaldoIRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Giuseppe AprileDepartment of Oncology, Ospedale San Bortolo, Vicenza, Veneto, Italy.
Giordano D BerettaMedical Oncology, Humanitas Gavazzeni, Bergamo, Lombardia, Italy.
Mario Negri Institute for Pharmacological Research · ITAgostino Gemelli University Polyclinic · ITAzienda Ospedaliera S.Maria · ITAzienda Ospedaliera Universitaria Pisana · ITCasa Sollievo della Sofferenza · ITCentro di Riferimento Oncologico · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITHumanitas Gavazzeni · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITOspedale Papa Giovanni XXIII · ITOspedale San Bortolo · ITOspedale San Carlo · ITPoliclinico Umberto I · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Ragusa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About 75% of colorectal cancers are diagnosed as early stage, in which radical surgery is achievable. In the last decade, in Italy, the overall incidence of colorectal cancer has remained stable, while mortality gradually decreased, which is attributable to early diagnosis and improved medical, surgical and locoregional treatments. The Italian Medical Oncology Association formulated guidelines to manage early-stage colon cancer, including screening, diagnosis, treatment and follow-up, which we herein present.

Indexed as

Colonic NeoplasmsMedical OncologyHumansIncidenceItalyNeoplasm Stagingearly colon canceritalian guidelinesoncology

Identifiers

PMID33262200
PMCPMC7709518
OpenAlexW3110634779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.